Follow this preprint

Associations of DMT therapies with COVID-19 severity in multiple sclerosis

Steve Simpson-Yap, Edward De Brouwer, Tomas Kalincik, Nick Rijke, Jan Hillert, Clare Walton, Gilles Edan, Yves Moreau, Tim Spelman, Lotte Geys, Tina Parciak, Clément Gautrais, Nikola Lazovski, Ashkan Pirmani, Amin Ardeshirdavani, Lars Forsberg, Anna Glaser, Robert McBurney, Hollie Schmidt, Arnfin Bergmann, Stefan Braune, Alexander Stahmann, Rodden Middleton, Amber Salter, Robert J. Fox, Anneke van der Walt, Helmut Butzkueven, Raed Al-Roughani, Serkan Ozakbas, Juan I Rojas, Ingrid van der Mei, Nupur Nag, Rumen Ivanov, Guilherme Sciascia do Olival, Alice Estavo Dias, Melinda Magyari, Doralina Guimarães Brum, Maria Fernanda Mendes, Ricardo Alonso, Richard Nicholas, Johana Bauer, Anibal Chertcoff, Ana Zabalza, Georgina Arrambide, Alexander Fidao, Giancarlo Comi, Liesbet M. Peeters
doi: https://doi.org/10.1101/2021.02.08.21251316
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.

Article Information

doi 
https://doi.org/10.1101/2021.02.08.21251316
History 
  • February 10, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Steve Simpson-Yap1,2,3,
  2. Edward De Brouwer4,
  3. Tomas Kalincik1,5,
  4. Nick Rijke6,
  5. Jan Hillert7,
  6. Clare Walton6,
  7. Gilles Edan8,
  8. Yves Moreau4,
  9. Tim Spelman7,9,
  10. Lotte Geys10,
  11. Tina Parciak10,11,
  12. Clément Gautrais12,
  13. Nikola Lazovski13,
  14. Ashkan Pirmani4,10,
  15. Amin Ardeshirdavani4,
  16. Lars Forsberg7,
  17. Anna Glaser9,
  18. Robert McBurney14,
  19. Hollie Schmidt14,
  20. Arnfin Bergmann15,
  21. Stefan Braune15,
  22. Alexander Stahmann16,
  23. Rodden Middleton17,
  24. Amber Salter18,19,
  25. Robert J. Fox18,20,
  26. Anneke van der Walt21,
  27. Helmut Butzkueven21,
  28. Raed Al-Roughani22,
  29. Serkan Ozakbas23,
  30. Juan I Rojas24,25,
  31. Ingrid van der Mei26,
  32. Nupur Nag2,
  33. Rumen Ivanov27,
  34. Guilherme Sciascia do Olival28,
  35. Alice Estavo Dias28,
  36. Melinda Magyari29,
  37. Doralina Guimarães Brum30,31,
  38. Maria Fernanda Mendes31,32,
  39. Ricardo Alonso25,33,
  40. Richard Nicholas17,34,35,
  41. Johana Bauer36,
  42. Anibal Chertcoff37,
  43. Ana Zabalza38,
  44. Georgina Arrambide38,
  45. Alexander Fidao2,
  46. Giancarlo Comi39 and
  47. Liesbet M. Peeters10,*
  1. 1CORe, Department of Medicine, The University of Melbourne, Australia
  2. 2Neuroepidemiology Unit, Melbourne School of Population & Global Health, The University of Melbourne, Australia
  3. 3Menzies Institute for Medical Research, University of Tasmania, Australia
  4. 4ESAT-STADIUS, KU Leuven, Belgium
  5. 5Melbourne MS Centre, Department of Neurology, Royal Melbourne Hospital, Australia
  6. 6MS International Federation, United Kingdom
  7. 7Department of Clinical Neuroscience, Swedish MS Registry, Sweden
  8. 8Department of Neurology, CHU Pontchaillou, France
  9. 9Karolinska Institutet, Sweden
  10. 10Biomedical Research Institute - Data Science Institute, Hasselt University, Belgium
  11. 11Department of Medical Informatics, University Medical Center Göttingen, Germany
  12. 12Department of Computer Science and AI, KU Leuven, Belgium
  13. 13QMENTA, Spain
  14. 14iConquerMS People-Powered Research Network, Accelerated Cure Project for MS, United States of America
  15. 15NeuroTransData Study Group, NeuroTransData, Germany
  16. 16German MS-Register by the National MS Society, MS Forschungs- und Projektentwicklungs-gGmbH, Germany
  17. 17UK MS Register, Swansea University, United Kingdom
  18. 18COViMS, United States of America
  19. 19Division of Biostatistics, Washington University in St Louis, United States of America
  20. 20Mellen Center for Multiple Sclerosis, Cleveland Clinic, United States of America
  21. 21Department of Neuroscience, Central Clinical School, Monash University, Australia
  22. 22Dokuz Eylul University, Turkey
  23. 23Division of Neurology, Department of Medicine, Amiri Hospital, Kuwait
  24. 24Neurology Department, Hospital Universitario de CEMIC, Argentina
  25. 25RELACOEM, Argentina
  26. 26The Australian MS Longitudinal Study, Menzies Institute for Medical Research, University of Tasmania, Australia
  27. 27Bulgarian SmartMS COVID-19 Dataset, Bulgaria
  28. 28ABEM - Brazilian MS Patients Association, Brazil
  29. 29The Danish Multiple Sclerosis Registry, Departement of Neurology, University Hospital Rigshospitalet, Denmark
  30. 30Universidade Estadual Paulista, Unesp, Faculdade de Medicina, Botucatu, Brazil
  31. 31REDONE.br – Brazilian Registry of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders, Brazil
  32. 32Irmandade da Santa Casa de Misericórdia de São Paulo, Brazil
  33. 33Multiple Sclerosis University Center, Ramos Mejia Hospital – EMA, Argentina
  34. 34Imperial College London, United Kingdom
  35. 35Swansea University, United Kingdom
  36. 36Mental Health Area, EMA, Argentina
  37. 37MS and Demyelinating Diseases. Hospital Británico de Buenos Aires, EMA, Argentina
  38. 38Servei de Neurologia-Neuroimmunologia. Centre d’Esclerosi Múltiple de Catalunya, (Cemcat). Vall d’Hebron Institut de Recerca, Vall d’Hebron Hospital Universitari. Universitat Autònoma de Barcelona, Spain
  39. 39Institute of Experimental Neurology, Ospedale San Raffaele, Italy
  1. ↵*Corresponding author: Professor Dr Liesbet M Peeters, Biomedical Research Institute & Data Science Institute, Hasselt University, Belgium, liesbet.peeters{at}uhasselt.be
Back to top
Posted February 10, 2021.
Download PDF
Print/Save Options
Download PDFFull Text & In-line FiguresXML

Supplementary Material

Data/Code
Email
Associations of DMT therapies with COVID-19 severity in multiple sclerosis
Steve Simpson-Yap, Edward De Brouwer, Tomas Kalincik, Nick Rijke, Jan Hillert, Clare Walton, Gilles Edan, Yves Moreau, Tim Spelman, Lotte Geys, Tina Parciak, Clément Gautrais, Nikola Lazovski, Ashkan Pirmani, Amin Ardeshirdavani, Lars Forsberg, Anna Glaser, Robert McBurney, Hollie Schmidt, Arnfin Bergmann, Stefan Braune, Alexander Stahmann, Rodden Middleton, Amber Salter, Robert J. Fox, Anneke van der Walt, Helmut Butzkueven, Raed Al-Roughani, Serkan Ozakbas, Juan I Rojas, Ingrid van der Mei, Nupur Nag, Rumen Ivanov, Guilherme Sciascia do Olival, Alice Estavo Dias, Melinda Magyari, Doralina Guimarães Brum, Maria Fernanda Mendes, Ricardo Alonso, Richard Nicholas, Johana Bauer, Anibal Chertcoff, Ana Zabalza, Georgina Arrambide, Alexander Fidao, Giancarlo Comi, Liesbet M. Peeters
medRxiv 2021.02.08.21251316; doi: https://doi.org/10.1101/2021.02.08.21251316
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area

Reviews and Context

0

Comment

0

TRIP Peer Reviews

0

Community Reviews

0

Automated Services

3

Blogs/Media

0

Author Videos

You can now receive automatic notifications when a preprint is revised, withdrawn, commented on, peer reviewed, or published in a journal. Select the events you would like to follow below and click "Submit". To see all of the preprints you are currently following, please go to the medRxiv Alerts Page.

Sign In to Follow this Preprint

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.